About

Investor Relations

News

Research

Contact

Subscribe

CSE: DOCT

FSE: 7FM0

OTCQB: DOCKF

About

Investor Relations

News

Research

Contact

Subscribe

Beyond Medical Technologies Reports Robust H1 2025 Progress, Sets Stage for Republic Technologies

Beyond Medical Technologies Reports Robust H1 2025 Progress, Sets Stage for Republic Technologies

Onco-Innovations Limited

‹ Beyond Medical Technologies Announces Corporate Name Change to Republic Technologies

Beyond Medical Technologies Closes Second Tranche of Convertible Note Financing ›